These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7912544)

  • 1. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
    Rhodes T; Barrand MA; Twentyman PR
    Br J Cancer; 1994 Jul; 70(1):60-6. PubMed ID: 7912544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
    Coley HM; Workman P; Twentyman PR
    Br J Cancer; 1991 Mar; 63(3):351-7. PubMed ID: 1672252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
    Coley HM; Amos WB; Twentyman PR; Workman P
    Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
    Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
    Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
    Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of vacuolar H(+)-adenosine triphosphatase activity in multidrug resistance in HL60 cells.
    Marquardt D; Center MS
    J Natl Cancer Inst; 1991 Aug; 83(15):1098-102. PubMed ID: 1831509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
    Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
    Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion.
    Verovski VN; Van den Berge DL; Delvaeye MM; Scheper RJ; De Neve WJ; Storme GA
    Br J Cancer; 1996 Mar; 73(5):596-602. PubMed ID: 8605092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.
    Hurwitz SJ; Terashima M; Mizunuma N; Slapak CA
    Blood; 1997 May; 89(10):3745-54. PubMed ID: 9160680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
    Michieli M; Michelutti A; Damiani D; Pipan C; Raspadori D; Lauria F; Baccarani M
    Leuk Lymphoma; 1993 Feb; 9(3):255-64. PubMed ID: 8097129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
    Schuurhuis GJ; Broxterman HJ; de Lange JH; Pinedo HM; van Heijningen TH; Kuiper CM; Scheffer GL; Scheper RJ; van Kalken CK; Baak JP
    Br J Cancer; 1991 Nov; 64(5):857-61. PubMed ID: 1681887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monensin and verapamil do not alter intracellular localisation of daunorubicin in multidrug resistant human KB cells.
    Wood DJ; Rumsby MG; Warr JR
    Cancer Lett; 1996 Nov; 108(1):41-7. PubMed ID: 8950207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by acrolein and chloroacetaldehyde of multidrug resistance mediated by the multidrug resistance-associated protein (MRP).
    Manzano RG; Wright KA; Twentyman PR
    Clin Cancer Res; 1996 Aug; 2(8):1321-6. PubMed ID: 9816303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.